| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| General Surgery | 9 | 2019 | 228 | 2.560 |
Why?
|
| Surgical Procedures, Operative | 8 | 2021 | 182 | 2.140 |
Why?
|
| Delivery of Health Care | 6 | 2021 | 426 | 1.810 |
Why?
|
| Ischemia | 26 | 2011 | 243 | 1.750 |
Why?
|
| Risk Management | 2 | 2023 | 43 | 1.540 |
Why?
|
| Patient Care Team | 6 | 2021 | 280 | 1.510 |
Why?
|
| Academic Medical Centers | 4 | 2023 | 379 | 1.470 |
Why?
|
| Trauma Centers | 6 | 2021 | 116 | 1.340 |
Why?
|
| Surgeons | 5 | 2021 | 238 | 1.330 |
Why?
|
| Endothelium, Vascular | 13 | 2002 | 435 | 1.300 |
Why?
|
| Interprofessional Relations | 3 | 2021 | 121 | 1.290 |
Why?
|
| Medical Staff, Hospital | 2 | 2021 | 107 | 1.260 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2013 | 112 | 1.170 |
Why?
|
| Patient Care | 2 | 2019 | 100 | 1.150 |
Why?
|
| Endovascular Procedures | 4 | 2021 | 218 | 1.050 |
Why?
|
| Physicians | 4 | 2019 | 673 | 1.000 |
Why?
|
| Endarterectomy, Carotid | 9 | 2009 | 73 | 0.960 |
Why?
|
| Failure to Rescue, Health Care | 3 | 2017 | 3 | 0.910 |
Why?
|
| Medical Errors | 3 | 2023 | 115 | 0.900 |
Why?
|
| Reperfusion Injury | 8 | 2005 | 131 | 0.900 |
Why?
|
| Leadership | 3 | 2016 | 134 | 0.880 |
Why?
|
| Research Report | 1 | 2023 | 44 | 0.880 |
Why?
|
| Humans | 144 | 2023 | 86617 | 0.880 |
Why?
|
| Benchmarking | 1 | 2023 | 78 | 0.870 |
Why?
|
| Wounds and Injuries | 6 | 2016 | 231 | 0.860 |
Why?
|
| Hospital Administrators | 1 | 2021 | 4 | 0.840 |
Why?
|
| Emotions | 2 | 2021 | 341 | 0.840 |
Why?
|
| Value-Based Purchasing | 1 | 2021 | 4 | 0.840 |
Why?
|
| Patient Safety | 3 | 2020 | 212 | 0.830 |
Why?
|
| Hospital Mortality | 5 | 2020 | 349 | 0.800 |
Why?
|
| Resuscitation Orders | 2 | 2021 | 62 | 0.770 |
Why?
|
| E-Selectin | 8 | 1998 | 30 | 0.760 |
Why?
|
| Aorta, Abdominal | 8 | 2013 | 60 | 0.740 |
Why?
|
| Vascular Surgical Procedures | 7 | 2010 | 148 | 0.730 |
Why?
|
| Perioperative Care | 1 | 2021 | 161 | 0.720 |
Why?
|
| Elective Surgical Procedures | 3 | 2020 | 116 | 0.700 |
Why?
|
| Quality Assurance, Health Care | 3 | 2019 | 220 | 0.700 |
Why?
|
| Inventions | 1 | 2019 | 13 | 0.690 |
Why?
|
| Famous Persons | 1 | 2019 | 14 | 0.680 |
Why?
|
| Biomedical Technology | 1 | 2019 | 20 | 0.680 |
Why?
|
| Emotional Intelligence | 1 | 2019 | 22 | 0.670 |
Why?
|
| Neutrophils | 6 | 2005 | 307 | 0.670 |
Why?
|
| Malpractice | 1 | 2019 | 57 | 0.660 |
Why?
|
| Interdisciplinary Communication | 2 | 2016 | 130 | 0.640 |
Why?
|
| Peer Review, Health Care | 1 | 2018 | 5 | 0.640 |
Why?
|
| Reperfusion | 4 | 2015 | 31 | 0.620 |
Why?
|
| Systems Analysis | 2 | 2014 | 17 | 0.610 |
Why?
|
| Interleukin-1 | 5 | 1997 | 71 | 0.610 |
Why?
|
| Mesenteric Arteries | 6 | 1997 | 29 | 0.580 |
Why?
|
| Arterial Occlusive Diseases | 12 | 2005 | 107 | 0.580 |
Why?
|
| United States | 19 | 2023 | 6665 | 0.570 |
Why?
|
| Mesenteric Ischemia | 1 | 2015 | 4 | 0.550 |
Why?
|
| Catheterization | 3 | 2017 | 232 | 0.550 |
Why?
|
| Postoperative Complications | 11 | 2020 | 2207 | 0.550 |
Why?
|
| Laparotomy | 1 | 2015 | 59 | 0.540 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 144 | 0.540 |
Why?
|
| Attitude of Health Personnel | 3 | 2019 | 636 | 0.530 |
Why?
|
| Healthcare Disparities | 2 | 2010 | 370 | 0.510 |
Why?
|
| Fatigue | 1 | 2015 | 174 | 0.510 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2014 | 8 | 0.510 |
Why?
|
| Students, Medical | 1 | 2019 | 384 | 0.500 |
Why?
|
| Biomedical Research | 1 | 2019 | 375 | 0.500 |
Why?
|
| Blood Vessel Prosthesis Implantation | 10 | 2020 | 208 | 0.500 |
Why?
|
| Sleep Deprivation | 1 | 2015 | 137 | 0.500 |
Why?
|
| Health Status | 1 | 2017 | 360 | 0.500 |
Why?
|
| Aged | 49 | 2021 | 18402 | 0.500 |
Why?
|
| Leg | 11 | 2004 | 137 | 0.490 |
Why?
|
| Intestine, Small | 6 | 1996 | 303 | 0.490 |
Why?
|
| Pulmonary Embolism | 6 | 2020 | 222 | 0.480 |
Why?
|
| Carotid Stenosis | 7 | 2012 | 112 | 0.480 |
Why?
|
| Male | 71 | 2023 | 40958 | 0.460 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 610 | 0.460 |
Why?
|
| Angioplasty | 3 | 2021 | 70 | 0.460 |
Why?
|
| Critical Care | 2 | 2016 | 370 | 0.440 |
Why?
|
| Cerebrovascular Disorders | 3 | 2012 | 143 | 0.440 |
Why?
|
| Hospitalization | 5 | 2023 | 849 | 0.430 |
Why?
|
| Aortic Rupture | 1 | 2013 | 55 | 0.430 |
Why?
|
| Middle Aged | 47 | 2023 | 25017 | 0.430 |
Why?
|
| Carotid Artery Diseases | 5 | 2009 | 97 | 0.430 |
Why?
|
| Clinical Competence | 2 | 2015 | 751 | 0.430 |
Why?
|
| Ossification, Heterotopic | 1 | 2012 | 31 | 0.430 |
Why?
|
| Angioscopy | 1 | 2011 | 3 | 0.420 |
Why?
|
| Venous Thromboembolism | 3 | 2020 | 153 | 0.410 |
Why?
|
| Operating Rooms | 4 | 2022 | 126 | 0.410 |
Why?
|
| Female | 65 | 2023 | 44509 | 0.410 |
Why?
|
| Retrospective Studies | 25 | 2023 | 8477 | 0.400 |
Why?
|
| Aneurysm, Ruptured | 1 | 2011 | 51 | 0.400 |
Why?
|
| Interleukin-6 | 3 | 2002 | 256 | 0.400 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 1998 | 683 | 0.400 |
Why?
|
| Internship and Residency | 2 | 2019 | 1004 | 0.390 |
Why?
|
| Ergonomics | 3 | 2022 | 21 | 0.370 |
Why?
|
| Intestines | 6 | 1999 | 411 | 0.370 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2011 | 87 | 0.370 |
Why?
|
| Angioplasty, Balloon | 7 | 2012 | 95 | 0.370 |
Why?
|
| Age Factors | 5 | 2020 | 1849 | 0.370 |
Why?
|
| Robotic Surgical Procedures | 3 | 2022 | 267 | 0.370 |
Why?
|
| Anticoagulants | 5 | 2020 | 408 | 0.370 |
Why?
|
| Aorta | 6 | 2021 | 280 | 0.370 |
Why?
|
| Cooperative Behavior | 3 | 2021 | 174 | 0.360 |
Why?
|
| Happiness | 1 | 2009 | 12 | 0.360 |
Why?
|
| Saphenous Vein | 8 | 2002 | 61 | 0.340 |
Why?
|
| Blood Vessel Prosthesis | 10 | 2005 | 228 | 0.340 |
Why?
|
| Renal Circulation | 7 | 2000 | 61 | 0.340 |
Why?
|
| Risk Assessment | 5 | 2016 | 2261 | 0.330 |
Why?
|
| Venous Thrombosis | 3 | 2020 | 243 | 0.330 |
Why?
|
| Aorta, Thoracic | 5 | 2021 | 165 | 0.320 |
Why?
|
| Time Factors | 16 | 2022 | 5209 | 0.320 |
Why?
|
| Aortic Diseases | 4 | 2020 | 100 | 0.320 |
Why?
|
| Length of Stay | 7 | 2020 | 700 | 0.320 |
Why?
|
| Oxygen Consumption | 6 | 1996 | 239 | 0.320 |
Why?
|
| Stents | 3 | 2012 | 377 | 0.320 |
Why?
|
| Femoral Artery | 10 | 2002 | 81 | 0.320 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2010 | 581 | 0.320 |
Why?
|
| Enoxaparin | 2 | 2018 | 23 | 0.310 |
Why?
|
| Incidence | 3 | 2023 | 1577 | 0.310 |
Why?
|
| Aged, 80 and over | 17 | 2021 | 6501 | 0.310 |
Why?
|
| Celiac Artery | 3 | 1997 | 25 | 0.300 |
Why?
|
| Factor Xa Inhibitors | 2 | 2018 | 22 | 0.300 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 1998 | 71 | 0.290 |
Why?
|
| Adult | 35 | 2021 | 25640 | 0.290 |
Why?
|
| Intelligence | 1 | 2006 | 71 | 0.280 |
Why?
|
| Intensive Care Units | 3 | 2018 | 373 | 0.280 |
Why?
|
| Vascular Patency | 9 | 2004 | 126 | 0.270 |
Why?
|
| Kidney | 9 | 1988 | 1241 | 0.270 |
Why?
|
| Umbilical Veins | 7 | 2002 | 46 | 0.270 |
Why?
|
| Cells, Cultured | 11 | 2002 | 2818 | 0.260 |
Why?
|
| Treatment Outcome | 14 | 2020 | 7990 | 0.260 |
Why?
|
| Cell Membrane Permeability | 4 | 1999 | 119 | 0.260 |
Why?
|
| Oxygen | 7 | 1999 | 726 | 0.260 |
Why?
|
| Capillary Permeability | 4 | 2002 | 130 | 0.250 |
Why?
|
| Risk Factors | 13 | 2020 | 5417 | 0.240 |
Why?
|
| Renal Artery | 6 | 2000 | 64 | 0.240 |
Why?
|
| Cell Hypoxia | 3 | 2002 | 164 | 0.240 |
Why?
|
| Arteriosclerosis | 10 | 2002 | 113 | 0.220 |
Why?
|
| Carotid Artery, Common | 1 | 2002 | 29 | 0.220 |
Why?
|
| Motivation | 2 | 2019 | 287 | 0.210 |
Why?
|
| Hospital Administration | 1 | 2021 | 26 | 0.200 |
Why?
|
| Homeostasis | 6 | 1990 | 409 | 0.200 |
Why?
|
| Iliac Artery | 4 | 2002 | 35 | 0.200 |
Why?
|
| Hemorrhage | 4 | 2016 | 268 | 0.200 |
Why?
|
| Protein Kinase C | 1 | 2002 | 270 | 0.200 |
Why?
|
| Conservative Treatment | 1 | 2021 | 20 | 0.200 |
Why?
|
| Renal Artery Obstruction | 3 | 2000 | 39 | 0.190 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2021 | 92 | 0.190 |
Why?
|
| Faculty, Medical | 3 | 2019 | 178 | 0.190 |
Why?
|
| Intraoperative Complications | 3 | 1999 | 185 | 0.190 |
Why?
|
| Injury Severity Score | 2 | 2021 | 111 | 0.190 |
Why?
|
| Cytokines | 3 | 2005 | 776 | 0.190 |
Why?
|
| Equipment and Supplies | 1 | 2020 | 30 | 0.190 |
Why?
|
| Jejunum | 2 | 1996 | 79 | 0.190 |
Why?
|
| Vascular System Injuries | 1 | 2021 | 29 | 0.190 |
Why?
|
| Reactive Oxygen Species | 2 | 2002 | 480 | 0.190 |
Why?
|
| Anastomosis, Surgical | 3 | 1997 | 267 | 0.190 |
Why?
|
| Appendectomy | 1 | 2020 | 33 | 0.190 |
Why?
|
| Cross Infection | 2 | 2020 | 141 | 0.190 |
Why?
|
| Medical Staff | 1 | 2020 | 10 | 0.180 |
Why?
|
| Electroencephalography | 5 | 1999 | 709 | 0.180 |
Why?
|
| Awareness | 1 | 2020 | 93 | 0.180 |
Why?
|
| Infection Control | 1 | 2021 | 115 | 0.180 |
Why?
|
| Databases, Factual | 3 | 2020 | 812 | 0.180 |
Why?
|
| Health Care Costs | 2 | 2019 | 237 | 0.180 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 53 | 0.180 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 257 | 0.170 |
Why?
|
| Brain Ischemia | 4 | 1999 | 398 | 0.170 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 190 | 0.170 |
Why?
|
| Limb Salvage | 3 | 2004 | 31 | 0.170 |
Why?
|
| Privacy | 1 | 2019 | 20 | 0.170 |
Why?
|
| Dogs | 16 | 1999 | 685 | 0.170 |
Why?
|
| Career Choice | 2 | 2011 | 139 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2013 | 2601 | 0.170 |
Why?
|
| Cell Adhesion | 3 | 1997 | 420 | 0.170 |
Why?
|
| Efficiency, Organizational | 2 | 2016 | 58 | 0.170 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2001 | 62 | 0.170 |
Why?
|
| Perception | 1 | 2020 | 168 | 0.170 |
Why?
|
| Computers | 1 | 2018 | 112 | 0.170 |
Why?
|
| Cost Savings | 1 | 2019 | 66 | 0.170 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1998 | 27 | 0.160 |
Why?
|
| Hemodynamics | 7 | 2011 | 710 | 0.160 |
Why?
|
| Teaching Rounds | 1 | 2018 | 24 | 0.160 |
Why?
|
| Dopamine | 3 | 1988 | 275 | 0.160 |
Why?
|
| Prospective Studies | 9 | 2020 | 4212 | 0.160 |
Why?
|
| Quality Improvement | 2 | 2020 | 428 | 0.160 |
Why?
|
| Factor Analysis, Statistical | 1 | 2018 | 111 | 0.160 |
Why?
|
| Residence Characteristics | 2 | 2010 | 197 | 0.160 |
Why?
|
| Hospitals, University | 1 | 1998 | 194 | 0.160 |
Why?
|
| Emergency Treatment | 2 | 2019 | 39 | 0.160 |
Why?
|
| Information Systems | 1 | 1997 | 29 | 0.150 |
Why?
|
| Endarterectomy | 5 | 1996 | 20 | 0.150 |
Why?
|
| Blood Proteins | 1 | 1998 | 144 | 0.150 |
Why?
|
| Mesentery | 1 | 1997 | 45 | 0.150 |
Why?
|
| Communication | 2 | 2018 | 441 | 0.150 |
Why?
|
| Conversion to Open Surgery | 1 | 2017 | 11 | 0.150 |
Why?
|
| Radiography | 10 | 2005 | 813 | 0.150 |
Why?
|
| Splanchnic Circulation | 3 | 1997 | 16 | 0.150 |
Why?
|
| Patient Acuity | 1 | 2017 | 32 | 0.150 |
Why?
|
| Patient Rights | 1 | 2017 | 16 | 0.150 |
Why?
|
| Regional Blood Flow | 11 | 1990 | 197 | 0.150 |
Why?
|
| Animals | 30 | 2019 | 26582 | 0.150 |
Why?
|
| Premedication | 1 | 2016 | 54 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 1034 | 0.140 |
Why?
|
| Vascular Resistance | 6 | 1991 | 102 | 0.140 |
Why?
|
| Fractures, Bone | 1 | 2018 | 131 | 0.140 |
Why?
|
| Efficiency | 1 | 2016 | 40 | 0.140 |
Why?
|
| Personal Autonomy | 1 | 2017 | 112 | 0.140 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 1998 | 237 | 0.140 |
Why?
|
| Patents as Topic | 1 | 1996 | 12 | 0.140 |
Why?
|
| Ischemic Attack, Transient | 3 | 2012 | 181 | 0.140 |
Why?
|
| Operative Time | 1 | 2016 | 127 | 0.140 |
Why?
|
| Albumins | 1 | 1996 | 133 | 0.140 |
Why?
|
| Patient Preference | 1 | 2017 | 105 | 0.140 |
Why?
|
| Heparin | 1 | 2016 | 175 | 0.140 |
Why?
|
| Follow-Up Studies | 9 | 2011 | 3636 | 0.140 |
Why?
|
| Lower Extremity | 2 | 2018 | 84 | 0.130 |
Why?
|
| Nephrectomy | 5 | 2016 | 294 | 0.130 |
Why?
|
| Patient Selection | 2 | 2015 | 685 | 0.130 |
Why?
|
| Prevalence | 2 | 2010 | 1239 | 0.130 |
Why?
|
| Spinal Cord | 2 | 1994 | 249 | 0.130 |
Why?
|
| Carotid Arteries | 5 | 1997 | 127 | 0.130 |
Why?
|
| Electric Impedance | 3 | 2002 | 104 | 0.130 |
Why?
|
| Acute Disease | 4 | 2011 | 826 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 1996 | 151 | 0.130 |
Why?
|
| Interpersonal Relations | 1 | 2016 | 170 | 0.130 |
Why?
|
| Adolescent | 11 | 2017 | 8979 | 0.130 |
Why?
|
| Angiography | 7 | 2000 | 208 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
| Anesthesia | 1 | 2017 | 164 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
| Behavior | 1 | 2015 | 85 | 0.130 |
Why?
|
| Rats | 8 | 1999 | 3990 | 0.130 |
Why?
|
| Systems Integration | 1 | 2014 | 35 | 0.130 |
Why?
|
| Celiac Plexus | 1 | 1994 | 3 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 202 | 0.120 |
Why?
|
| Mesenteric Artery, Superior | 1 | 1994 | 19 | 0.120 |
Why?
|
| Liver | 2 | 1996 | 1230 | 0.120 |
Why?
|
| Monitoring, Physiologic | 4 | 2018 | 268 | 0.120 |
Why?
|
| Nerve Compression Syndromes | 1 | 1994 | 18 | 0.120 |
Why?
|
| Hypoxia | 1 | 1999 | 641 | 0.120 |
Why?
|
| Ligaments | 1 | 1994 | 32 | 0.120 |
Why?
|
| Informed Consent | 1 | 2017 | 266 | 0.120 |
Why?
|
| Arteries | 7 | 1994 | 176 | 0.120 |
Why?
|
| Veins | 5 | 2000 | 94 | 0.120 |
Why?
|
| Diseases in Twins | 1 | 1994 | 65 | 0.120 |
Why?
|
| Focus Groups | 1 | 2014 | 155 | 0.120 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 484 | 0.120 |
Why?
|
| Recurrence | 8 | 2002 | 1139 | 0.120 |
Why?
|
| Laparoscopy | 1 | 2020 | 754 | 0.120 |
Why?
|
| Time-to-Treatment | 1 | 2014 | 97 | 0.120 |
Why?
|
| Aneurysm | 3 | 1991 | 58 | 0.110 |
Why?
|
| Dilatation, Pathologic | 1 | 2013 | 54 | 0.110 |
Why?
|
| Myocardium | 2 | 1986 | 529 | 0.110 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 86 | 0.110 |
Why?
|
| Massage | 1 | 2012 | 3 | 0.110 |
Why?
|
| Prostatectomy | 1 | 2016 | 471 | 0.110 |
Why?
|
| Neck Pain | 1 | 2012 | 17 | 0.110 |
Why?
|
| Survival Analysis | 6 | 2003 | 1538 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2002 | 40 | 0.110 |
Why?
|
| Dizziness | 1 | 2012 | 27 | 0.110 |
Why?
|
| Osteotomy | 1 | 2012 | 31 | 0.110 |
Why?
|
| Syncope | 1 | 2012 | 34 | 0.110 |
Why?
|
| Posture | 1 | 2012 | 125 | 0.110 |
Why?
|
| Safety | 1 | 2012 | 152 | 0.100 |
Why?
|
| Glucagon | 2 | 1990 | 111 | 0.100 |
Why?
|
| Temporal Bone | 1 | 2012 | 66 | 0.100 |
Why?
|
| Patient Handoff | 1 | 2013 | 93 | 0.100 |
Why?
|
| Forearm | 1 | 1991 | 32 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 1991 | 93 | 0.100 |
Why?
|
| NF-kappa B | 3 | 2002 | 444 | 0.100 |
Why?
|
| Decision Making | 1 | 2017 | 642 | 0.100 |
Why?
|
| Chronic Disease | 4 | 1997 | 971 | 0.100 |
Why?
|
| Thrombectomy | 1 | 2012 | 158 | 0.100 |
Why?
|
| Physicians, Women | 1 | 2011 | 53 | 0.100 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 1990 | 6 | 0.090 |
Why?
|
| Lung | 1 | 1996 | 1170 | 0.090 |
Why?
|
| Colorectal Surgery | 1 | 2010 | 22 | 0.090 |
Why?
|
| Hemodilution | 1 | 1990 | 13 | 0.090 |
Why?
|
| Hand | 1 | 1991 | 130 | 0.090 |
Why?
|
| Databases as Topic | 1 | 2010 | 92 | 0.090 |
Why?
|
| Preoperative Care | 3 | 2020 | 394 | 0.090 |
Why?
|
| Los Angeles | 2 | 2020 | 28 | 0.090 |
Why?
|
| Diffusion of Innovation | 1 | 2010 | 71 | 0.090 |
Why?
|
| Nitroglycerin | 2 | 1986 | 22 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2010 | 278 | 0.090 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2011 | 160 | 0.090 |
Why?
|
| Signal Transduction | 1 | 1999 | 3241 | 0.080 |
Why?
|
| Job Satisfaction | 1 | 2009 | 73 | 0.080 |
Why?
|
| Heart Diseases | 2 | 2009 | 290 | 0.080 |
Why?
|
| Myocardial Contraction | 2 | 1987 | 244 | 0.080 |
Why?
|
| Income | 1 | 2009 | 75 | 0.080 |
Why?
|
| Carotid Artery, Internal | 4 | 2002 | 69 | 0.080 |
Why?
|
| Vasodilation | 2 | 2005 | 96 | 0.080 |
Why?
|
| Hospital Costs | 2 | 2000 | 104 | 0.080 |
Why?
|
| Educational Status | 1 | 2009 | 188 | 0.080 |
Why?
|
| Health Services Research | 1 | 2009 | 136 | 0.080 |
Why?
|
| Calcinosis | 3 | 2005 | 224 | 0.080 |
Why?
|
| Polytetrafluoroethylene | 3 | 2002 | 74 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2009 | 596 | 0.080 |
Why?
|
| Digitalis | 1 | 1987 | 2 | 0.080 |
Why?
|
| Plants, Toxic | 1 | 1987 | 26 | 0.080 |
Why?
|
| Plants, Medicinal | 1 | 1987 | 42 | 0.070 |
Why?
|
| Alkaline Phosphatase | 2 | 1999 | 132 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2002 | 1961 | 0.070 |
Why?
|
| Workplace | 1 | 2006 | 27 | 0.070 |
Why?
|
| Pentobarbital | 2 | 1985 | 20 | 0.070 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2004 | 99 | 0.070 |
Why?
|
| Endothelium | 3 | 2005 | 59 | 0.070 |
Why?
|
| In Vitro Techniques | 4 | 2005 | 989 | 0.070 |
Why?
|
| Embolism | 2 | 1997 | 31 | 0.070 |
Why?
|
| Prostaglandins | 1 | 1986 | 43 | 0.070 |
Why?
|
| Heart | 2 | 1986 | 539 | 0.070 |
Why?
|
| Professional Competence | 1 | 2006 | 68 | 0.070 |
Why?
|
| Prognosis | 3 | 2011 | 3675 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 125 | 0.070 |
Why?
|
| Coronary Disease | 1 | 1987 | 261 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2005 | 38 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 2006 | 157 | 0.070 |
Why?
|
| Vena Cava Filters | 1 | 2007 | 96 | 0.070 |
Why?
|
| Device Removal | 1 | 2007 | 161 | 0.070 |
Why?
|
| Models, Psychological | 1 | 2006 | 157 | 0.070 |
Why?
|
| Medicare | 1 | 2009 | 406 | 0.070 |
Why?
|
| Rats, Inbred Strains | 3 | 1991 | 312 | 0.070 |
Why?
|
| Societies, Medical | 2 | 2021 | 572 | 0.070 |
Why?
|
| Ischemic Preconditioning | 1 | 2005 | 37 | 0.070 |
Why?
|
| Intermittent Claudication | 2 | 2004 | 20 | 0.060 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1984 | 5 | 0.060 |
Why?
|
| Aneurysm, False | 1 | 2005 | 54 | 0.060 |
Why?
|
| Smoking | 1 | 2009 | 609 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2016 | 678 | 0.060 |
Why?
|
| Cell Membrane | 2 | 1997 | 666 | 0.060 |
Why?
|
| Bariatric Surgery | 1 | 2007 | 194 | 0.060 |
Why?
|
| Chicago | 3 | 2004 | 1379 | 0.060 |
Why?
|
| Blood Pressure | 9 | 1990 | 1143 | 0.060 |
Why?
|
| Leukocytes | 1 | 2005 | 202 | 0.060 |
Why?
|
| Intraoperative Care | 3 | 1998 | 82 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 1996 | 297 | 0.060 |
Why?
|
| Life Tables | 2 | 2000 | 48 | 0.060 |
Why?
|
| Diuresis | 3 | 1988 | 29 | 0.060 |
Why?
|
| Vascular Diseases | 3 | 1991 | 121 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2005 | 278 | 0.060 |
Why?
|
| Schools, Medical | 3 | 2000 | 123 | 0.060 |
Why?
|
| Natriuresis | 3 | 1988 | 30 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 2 | 1995 | 163 | 0.060 |
Why?
|
| Universities | 1 | 2004 | 135 | 0.060 |
Why?
|
| Thrombophilia | 1 | 2003 | 22 | 0.060 |
Why?
|
| Logistic Models | 2 | 2016 | 1185 | 0.060 |
Why?
|
| Hypertension, Renal | 2 | 2000 | 40 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2004 | 312 | 0.050 |
Why?
|
| Quality of Health Care | 2 | 2020 | 380 | 0.050 |
Why?
|
| Ethidium | 1 | 2002 | 13 | 0.050 |
Why?
|
| Personnel Turnover | 1 | 2022 | 7 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2005 | 447 | 0.050 |
Why?
|
| Enzyme Inhibitors | 2 | 2002 | 639 | 0.050 |
Why?
|
| Vena Cava, Inferior | 4 | 1989 | 143 | 0.050 |
Why?
|
| Young Adult | 4 | 2016 | 5974 | 0.050 |
Why?
|
| Carbazoles | 1 | 2002 | 51 | 0.050 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2002 | 70 | 0.050 |
Why?
|
| Constriction, Pathologic | 2 | 1994 | 213 | 0.050 |
Why?
|
| Antioxidants | 2 | 2002 | 223 | 0.050 |
Why?
|
| Echocardiography | 1 | 1987 | 911 | 0.050 |
Why?
|
| Intestinal Mucosa | 3 | 1999 | 797 | 0.050 |
Why?
|
| Peritoneal Dialysis | 1 | 1982 | 32 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 508 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 1982 | 61 | 0.050 |
Why?
|
| Unnecessary Procedures | 1 | 2002 | 51 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 316 | 0.050 |
Why?
|
| Hospital Bed Capacity | 1 | 2021 | 20 | 0.050 |
Why?
|
| Perfusion | 3 | 1996 | 203 | 0.050 |
Why?
|
| Mortality | 2 | 2021 | 149 | 0.050 |
Why?
|
| Antibodies | 2 | 1999 | 350 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2007 | 278 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2002 | 254 | 0.050 |
Why?
|
| Endoleak | 1 | 2021 | 35 | 0.050 |
Why?
|
| Cost Control | 1 | 2020 | 44 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2002 | 193 | 0.050 |
Why?
|
| Thrombosis | 4 | 1997 | 296 | 0.050 |
Why?
|
| Linear Models | 2 | 2016 | 421 | 0.050 |
Why?
|
| Comorbidity | 3 | 2016 | 943 | 0.050 |
Why?
|
| Anuria | 1 | 1980 | 6 | 0.050 |
Why?
|
| Oliguria | 1 | 1980 | 5 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 1980 | 22 | 0.050 |
Why?
|
| Indoles | 1 | 2002 | 318 | 0.050 |
Why?
|
| Cerebral Revascularization | 1 | 1980 | 26 | 0.050 |
Why?
|
| Kidney Cortex | 1 | 1980 | 33 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2002 | 197 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2002 | 460 | 0.050 |
Why?
|
| Azoles | 1 | 1999 | 3 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 73 | 0.050 |
Why?
|
| Organoselenium Compounds | 1 | 1999 | 4 | 0.050 |
Why?
|
| Isoindoles | 1 | 1999 | 14 | 0.050 |
Why?
|
| Wounds, Penetrating | 1 | 1980 | 46 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2001 | 233 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2000 | 285 | 0.050 |
Why?
|
| Stroke | 1 | 2009 | 965 | 0.040 |
Why?
|
| Vagotomy | 1 | 1979 | 12 | 0.040 |
Why?
|
| Patient Participation | 1 | 2021 | 216 | 0.040 |
Why?
|
| Kinetics | 1 | 2002 | 1513 | 0.040 |
Why?
|
| Oxidants | 1 | 1999 | 86 | 0.040 |
Why?
|
| Education, Medical | 2 | 2000 | 233 | 0.040 |
Why?
|
| Anesthesiology | 1 | 2021 | 157 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 2 | 2001 | 509 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2020 | 303 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 1999 | 158 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 2019 | 27 | 0.040 |
Why?
|
| Actins | 1 | 2002 | 451 | 0.040 |
Why?
|
| Inflammation | 1 | 2004 | 920 | 0.040 |
Why?
|
| Cattle | 1 | 2019 | 376 | 0.040 |
Why?
|
| Teaching | 1 | 2000 | 147 | 0.040 |
Why?
|
| Mitochondria | 1 | 2002 | 535 | 0.040 |
Why?
|
| Blood Physiological Phenomena | 1 | 1998 | 9 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 1990 | 104 | 0.040 |
Why?
|
| Monitoring, Intraoperative | 1 | 1999 | 109 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2501 | 0.040 |
Why?
|
| Lidocaine | 1 | 1978 | 63 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2002 | 1981 | 0.040 |
Why?
|
| Cytological Techniques | 1 | 1998 | 30 | 0.040 |
Why?
|
| Blood Coagulation Tests | 1 | 2018 | 35 | 0.040 |
Why?
|
| Filtration | 2 | 1989 | 25 | 0.040 |
Why?
|
| Necrosis | 3 | 1997 | 204 | 0.040 |
Why?
|
| Cardiac Output | 2 | 1982 | 156 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 47 | 0.040 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1997 | 39 | 0.040 |
Why?
|
| Pelvis | 1 | 2018 | 95 | 0.040 |
Why?
|
| Contusions | 1 | 1977 | 9 | 0.040 |
Why?
|
| Child | 5 | 2010 | 6926 | 0.040 |
Why?
|
| Solubility | 1 | 1997 | 177 | 0.040 |
Why?
|
| Assisted Circulation | 1 | 1977 | 15 | 0.040 |
Why?
|
| Heart Injuries | 1 | 1977 | 16 | 0.040 |
Why?
|
| Registries | 1 | 2021 | 702 | 0.040 |
Why?
|
| Kupffer Cells | 1 | 1996 | 13 | 0.040 |
Why?
|
| Aortic Aneurysm | 2 | 1990 | 80 | 0.040 |
Why?
|
| Medical Informatics | 1 | 1997 | 47 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 2 | 1988 | 384 | 0.040 |
Why?
|
| Reoperation | 3 | 2005 | 597 | 0.040 |
Why?
|
| Hematocrit | 1 | 2016 | 68 | 0.040 |
Why?
|
| Muscles | 1 | 1977 | 194 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 1998 | 435 | 0.040 |
Why?
|
| Cytochalasin D | 1 | 1996 | 14 | 0.040 |
Why?
|
| Rectal Diseases | 1 | 2016 | 24 | 0.040 |
Why?
|
| Equipment Design | 1 | 1998 | 406 | 0.040 |
Why?
|
| Phagocytosis | 1 | 1996 | 85 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 1998 | 679 | 0.040 |
Why?
|
| Small-Area Analysis | 1 | 1996 | 8 | 0.040 |
Why?
|
| Syndrome | 2 | 1994 | 446 | 0.040 |
Why?
|
| Cell Communication | 1 | 1997 | 194 | 0.040 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1977 | 78 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2016 | 173 | 0.040 |
Why?
|
| Gadolinium | 1 | 1996 | 103 | 0.040 |
Why?
|
| Colonic Diseases | 1 | 2016 | 65 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 2016 | 60 | 0.030 |
Why?
|
| Cats | 1 | 1996 | 303 | 0.030 |
Why?
|
| Morbidity | 1 | 1996 | 148 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2016 | 116 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1998 | 451 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 1014 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1995 | 11 | 0.030 |
Why?
|
| Mentors | 1 | 2016 | 76 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 1995 | 31 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2002 | 1196 | 0.030 |
Why?
|
| Tight Junctions | 1 | 1996 | 149 | 0.030 |
Why?
|
| Rectum | 1 | 1976 | 146 | 0.030 |
Why?
|
| Insurance, Health | 1 | 1996 | 160 | 0.030 |
Why?
|
| Up-Regulation | 1 | 1997 | 712 | 0.030 |
Why?
|
| Risk | 4 | 1987 | 674 | 0.030 |
Why?
|
| Health Care Reform | 1 | 1996 | 90 | 0.030 |
Why?
|
| Suture Techniques | 1 | 1995 | 135 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 1976 | 196 | 0.030 |
Why?
|
| Iron | 1 | 1995 | 164 | 0.030 |
Why?
|
| Blood Component Removal | 1 | 1994 | 24 | 0.030 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1994 | 18 | 0.030 |
Why?
|
| Postoperative Care | 2 | 2002 | 221 | 0.030 |
Why?
|
| Hematoma | 1 | 1975 | 104 | 0.030 |
Why?
|
| Microspheres | 4 | 1982 | 101 | 0.030 |
Why?
|
| Vena Cava, Superior | 1 | 1974 | 59 | 0.030 |
Why?
|
| Drainage | 1 | 1975 | 157 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 1994 | 57 | 0.030 |
Why?
|
| Popliteal Artery | 4 | 2002 | 27 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1996 | 139 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.030 |
Why?
|
| Constriction | 4 | 1986 | 27 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2013 | 29 | 0.030 |
Why?
|
| Coronary Circulation | 2 | 1985 | 130 | 0.030 |
Why?
|
| Liver Diseases | 1 | 1975 | 238 | 0.030 |
Why?
|
| Colitis | 1 | 1976 | 239 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2013 | 153 | 0.030 |
Why?
|
| Transportation of Patients | 1 | 2013 | 32 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 1997 | 469 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2003 | 1673 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 1994 | 217 | 0.030 |
Why?
|
| Heart Rate | 2 | 1985 | 492 | 0.030 |
Why?
|
| Methods | 4 | 1986 | 152 | 0.030 |
Why?
|
| Hypertension | 2 | 2001 | 1141 | 0.030 |
Why?
|
| Prostaglandins F | 2 | 1986 | 12 | 0.030 |
Why?
|
| Data Collection | 1 | 2013 | 372 | 0.030 |
Why?
|
| Prosthesis-Related Infections | 1 | 1992 | 58 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 1976 | 556 | 0.030 |
Why?
|
| California | 1 | 2011 | 138 | 0.030 |
Why?
|
| Rupture, Spontaneous | 3 | 2002 | 43 | 0.030 |
Why?
|
| Femoral Vein | 2 | 2002 | 35 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 1996 | 1920 | 0.020 |
Why?
|
| Intraoperative Period | 2 | 1987 | 90 | 0.020 |
Why?
|
| Compliance | 1 | 1990 | 23 | 0.020 |
Why?
|
| Central Venous Pressure | 1 | 1990 | 26 | 0.020 |
Why?
|
| Antigens, CD | 1 | 1992 | 458 | 0.020 |
Why?
|
| Sex Factors | 3 | 2003 | 1054 | 0.020 |
Why?
|
| Air Microbiology | 1 | 1969 | 5 | 0.020 |
Why?
|
| Ventilation | 1 | 1969 | 7 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2002 | 912 | 0.020 |
Why?
|
| Enzyme Induction | 2 | 2002 | 88 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 2 | 1987 | 212 | 0.020 |
Why?
|
| p-Aminohippuric Acid | 1 | 1988 | 4 | 0.020 |
Why?
|
| Aminohippuric Acids | 1 | 1988 | 7 | 0.020 |
Why?
|
| Cinnamates | 1 | 1988 | 8 | 0.020 |
Why?
|
| Costs and Cost Analysis | 2 | 2000 | 153 | 0.020 |
Why?
|
| Transplantation, Autologous | 2 | 2000 | 330 | 0.020 |
Why?
|
| Potassium | 1 | 1988 | 281 | 0.020 |
Why?
|
| Reference Values | 1 | 1988 | 674 | 0.020 |
Why?
|
| Digoxin | 1 | 1987 | 21 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2004 | 1801 | 0.020 |
Why?
|
| Mesenteric Veins | 1 | 1987 | 34 | 0.020 |
Why?
|
| Duodenum | 1 | 2007 | 100 | 0.020 |
Why?
|
| Esophagus | 1 | 1987 | 102 | 0.020 |
Why?
|
| Receptors, Dopamine | 1 | 1986 | 38 | 0.020 |
Why?
|
| Aortography | 2 | 2002 | 63 | 0.020 |
Why?
|
| Vasa Vasorum | 2 | 1984 | 4 | 0.020 |
Why?
|
| Prostaglandins D | 1 | 1986 | 15 | 0.020 |
Why?
|
| Prostaglandins E | 1 | 1986 | 19 | 0.020 |
Why?
|
| Prostaglandin D2 | 1 | 1986 | 27 | 0.020 |
Why?
|
| Kinins | 1 | 1986 | 31 | 0.020 |
Why?
|
| Dinoprost | 1 | 1986 | 26 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 1987 | 190 | 0.020 |
Why?
|
| Coronary Vessels | 2 | 1985 | 177 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1986 | 88 | 0.020 |
Why?
|
| Dinoprostone | 1 | 1986 | 69 | 0.020 |
Why?
|
| Aminophylline | 1 | 1985 | 14 | 0.020 |
Why?
|
| Kallikreins | 1 | 1986 | 47 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2007 | 150 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2003 | 2767 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2007 | 110 | 0.020 |
Why?
|
| Consciousness | 1 | 1985 | 26 | 0.020 |
Why?
|
| Ethanol | 1 | 1988 | 249 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 1985 | 30 | 0.020 |
Why?
|
| Pressure | 1 | 1985 | 165 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2705 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 751 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 1986 | 133 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 1985 | 80 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1988 | 418 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 1988 | 295 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 364 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2005 | 112 | 0.020 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 1984 | 49 | 0.010 |
Why?
|
| Heart Ventricles | 2 | 1986 | 760 | 0.010 |
Why?
|
| Streptokinase | 1 | 1983 | 12 | 0.010 |
Why?
|
| Warfarin | 1 | 2004 | 103 | 0.010 |
Why?
|
| Creatinine | 2 | 1982 | 338 | 0.010 |
Why?
|
| Inguinal Canal | 1 | 2003 | 5 | 0.010 |
Why?
|
| Sodium | 2 | 1982 | 341 | 0.010 |
Why?
|
| Microsurgery | 2 | 1981 | 84 | 0.010 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2004 | 71 | 0.010 |
Why?
|
| Adenosine | 1 | 1985 | 225 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 752 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1984 | 231 | 0.010 |
Why?
|
| Serologic Tests | 1 | 2003 | 41 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1985 | 271 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 2002 | 17 | 0.010 |
Why?
|
| Time | 1 | 2002 | 77 | 0.010 |
Why?
|
| Onium Compounds | 1 | 2002 | 4 | 0.010 |
Why?
|
| Rotenone | 1 | 2002 | 17 | 0.010 |
Why?
|
| Ferricyanides | 1 | 1982 | 1 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2002 | 43 | 0.010 |
Why?
|
| Deoxycholic Acid | 1 | 1982 | 10 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1982 | 32 | 0.010 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2002 | 12 | 0.010 |
Why?
|
| Acetophenones | 1 | 2002 | 27 | 0.010 |
Why?
|
| Uremia | 1 | 1982 | 15 | 0.010 |
Why?
|
| Potassium Radioisotopes | 1 | 1982 | 2 | 0.010 |
Why?
|
| Antipyrine | 1 | 1982 | 4 | 0.010 |
Why?
|
| Krypton | 1 | 1982 | 2 | 0.010 |
Why?
|
| Xenon Radioisotopes | 1 | 1982 | 10 | 0.010 |
Why?
|
| Body Water | 1 | 1982 | 35 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1982 | 45 | 0.010 |
Why?
|
| Allopurinol | 1 | 2002 | 80 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1988 | 849 | 0.010 |
Why?
|
| Hydrogen | 1 | 1982 | 47 | 0.010 |
Why?
|
| Lasers | 1 | 1982 | 106 | 0.010 |
Why?
|
| Wounds, Gunshot | 2 | 1980 | 71 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1982 | 54 | 0.010 |
Why?
|
| Cimetidine | 1 | 1981 | 7 | 0.010 |
Why?
|
| Chlorides | 1 | 1982 | 103 | 0.010 |
Why?
|
| Antacids | 1 | 1981 | 4 | 0.010 |
Why?
|
| Guanidines | 1 | 1981 | 31 | 0.010 |
Why?
|
| Stomach Ulcer | 1 | 1981 | 23 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 1982 | 123 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 999 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2002 | 373 | 0.010 |
Why?
|
| Graft Survival | 2 | 2001 | 884 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 242 | 0.010 |
Why?
|
| Pregnancy | 1 | 1988 | 2894 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 2000 | 49 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1980 | 23 | 0.010 |
Why?
|
| Relative Value Scales | 1 | 2000 | 9 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1981 | 493 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1982 | 306 | 0.010 |
Why?
|
| Renin | 2 | 1978 | 79 | 0.010 |
Why?
|
| Jugular Veins | 1 | 1979 | 69 | 0.010 |
Why?
|
| Anemia, Hypochromic | 1 | 1979 | 5 | 0.010 |
Why?
|
| Dumping Syndrome | 1 | 1979 | 5 | 0.010 |
Why?
|
| Sucrase | 1 | 1999 | 2 | 0.010 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1999 | 16 | 0.010 |
Why?
|
| Malabsorption Syndromes | 1 | 1979 | 21 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 1979 | 23 | 0.010 |
Why?
|
| alpha-Glucosidases | 1 | 1999 | 7 | 0.010 |
Why?
|
| Esophageal Perforation | 1 | 1979 | 18 | 0.010 |
Why?
|
| Peptic Ulcer | 1 | 1979 | 19 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1981 | 227 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2000 | 150 | 0.010 |
Why?
|
| Microvilli | 1 | 1999 | 43 | 0.010 |
Why?
|
| Free Radicals | 1 | 1999 | 73 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 858 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 1860 | 0.010 |
Why?
|
| Appendicitis | 1 | 1979 | 62 | 0.010 |
Why?
|
| Blood Volume | 1 | 1978 | 51 | 0.010 |
Why?
|
| Denervation | 1 | 1978 | 34 | 0.010 |
Why?
|
| Arteriovenous Fistula | 1 | 1978 | 52 | 0.010 |
Why?
|
| Diarrhea | 1 | 1979 | 182 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 1982 | 346 | 0.010 |
Why?
|
| Deglutition Disorders | 1 | 1979 | 115 | 0.010 |
Why?
|
| Tolazoline | 1 | 1977 | 1 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 1979 | 117 | 0.010 |
Why?
|
| Wound Healing | 1 | 1979 | 344 | 0.010 |
Why?
|
| Rupture | 1 | 1977 | 63 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 1830 | 0.010 |
Why?
|
| Hindlimb | 1 | 1977 | 89 | 0.010 |
Why?
|
| Economic Competition | 1 | 1996 | 12 | 0.010 |
Why?
|
| Interinstitutional Relations | 1 | 1996 | 28 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 1979 | 255 | 0.010 |
Why?
|
| Managed Care Programs | 1 | 1996 | 42 | 0.010 |
Why?
|
| Contrast Media | 1 | 1982 | 1078 | 0.010 |
Why?
|
| Hyperemia | 1 | 1976 | 19 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1977 | 152 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1977 | 188 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 1996 | 115 | 0.010 |
Why?
|
| Staphylococcus | 2 | 1979 | 24 | 0.010 |
Why?
|
| X-Rays | 1 | 1995 | 130 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1995 | 188 | 0.010 |
Why?
|
| Hypotension | 1 | 1976 | 70 | 0.010 |
Why?
|
| Research | 1 | 1996 | 253 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1995 | 205 | 0.010 |
Why?
|
| Venous Pressure | 1 | 1974 | 11 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1975 | 220 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1995 | 280 | 0.010 |
Why?
|
| Cardiac Tamponade | 1 | 1974 | 17 | 0.010 |
Why?
|
| Macrophages | 1 | 1997 | 554 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1977 | 3611 | 0.010 |
Why?
|
| Biomarkers | 1 | 1999 | 1718 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1995 | 937 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 1995 | 225 | 0.010 |
Why?
|
| Cryopreservation | 1 | 1992 | 68 | 0.010 |
Why?
|
| Base Sequence | 1 | 1995 | 2330 | 0.010 |
Why?
|
| Gene Expression | 1 | 1995 | 1284 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 1135 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 3030 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1992 | 182 | 0.010 |
Why?
|
| Enterobacter | 1 | 1969 | 1 | 0.010 |
Why?
|
| Housekeeping, Hospital | 1 | 1969 | 1 | 0.010 |
Why?
|
| Patient Isolators | 1 | 1969 | 1 | 0.010 |
Why?
|
| Proteus | 1 | 1969 | 2 | 0.010 |
Why?
|
| Micrococcus | 1 | 1969 | 8 | 0.010 |
Why?
|
| Air Conditioning | 1 | 1969 | 6 | 0.010 |
Why?
|
| Klebsiella | 1 | 1969 | 6 | 0.010 |
Why?
|
| Hospital Design and Construction | 1 | 1969 | 5 | 0.010 |
Why?
|
| Disinfectants | 1 | 1969 | 8 | 0.010 |
Why?
|
| Bacillus | 1 | 1969 | 12 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1974 | 1565 | 0.010 |
Why?
|
| Pseudomonas | 1 | 1969 | 51 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 1969 | 39 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1995 | 1208 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1989 | 66 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1992 | 996 | 0.010 |
Why?
|
| Microbial Collagenase | 1 | 1989 | 3 | 0.010 |
Why?
|
| Pancreatic Elastase | 1 | 1989 | 15 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 1976 | 711 | 0.010 |
Why?
|
| Ulcer | 1 | 1989 | 36 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1989 | 274 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 1969 | 132 | 0.010 |
Why?
|
| Equipment Failure | 1 | 1989 | 119 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1988 | 72 | 0.000 |
Why?
|
| Collagen | 1 | 1989 | 269 | 0.000 |
Why?
|
| Lipids | 1 | 1989 | 269 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1969 | 597 | 0.000 |
Why?
|
| Domperidone | 1 | 1986 | 8 | 0.000 |
Why?
|
| Receptors, Dopamine D1 | 1 | 1986 | 34 | 0.000 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1986 | 57 | 0.000 |
Why?
|
| Thromboembolism | 1 | 1986 | 119 | 0.000 |
Why?
|
| Benzazepines | 1 | 1986 | 89 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1986 | 196 | 0.000 |
Why?
|
| Probability | 1 | 1986 | 355 | 0.000 |
Why?
|
| Tensile Strength | 1 | 1984 | 79 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1986 | 695 | 0.000 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1983 | 34 | 0.000 |
Why?
|
| Clinical Trials as Topic | 2 | 1981 | 1169 | 0.000 |
Why?
|
| Swine | 1 | 1984 | 555 | 0.000 |
Why?
|
| Anesthesia, Inhalation | 1 | 1982 | 36 | 0.000 |
Why?
|
| Ventricular Function | 1 | 1982 | 53 | 0.000 |
Why?
|
| Extremities | 1 | 1983 | 165 | 0.000 |
Why?
|
| Brachiocephalic Trunk | 1 | 1981 | 14 | 0.000 |
Why?
|
| Cerebral Arteries | 1 | 1981 | 74 | 0.000 |
Why?
|
| Subclavian Artery | 1 | 1981 | 44 | 0.000 |
Why?
|
| Gastric Acidity Determination | 1 | 1981 | 2 | 0.000 |
Why?
|
| Thrombocytosis | 1 | 1981 | 8 | 0.000 |
Why?
|
| Random Allocation | 1 | 1981 | 332 | 0.000 |
Why?
|
| Intracranial Aneurysm | 1 | 1981 | 158 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1981 | 160 | 0.000 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1981 | 229 | 0.000 |
Why?
|
| Kidney Function Tests | 1 | 1978 | 123 | 0.000 |
Why?
|
| Metatarsus | 1 | 1977 | 2 | 0.000 |
Why?
|
| Peroneal Nerve | 1 | 1977 | 9 | 0.000 |
Why?
|
| Fibula | 1 | 1977 | 32 | 0.000 |
Why?
|
| Joint Dislocations | 1 | 1977 | 27 | 0.000 |
Why?
|
| Tibial Fractures | 1 | 1977 | 39 | 0.000 |
Why?
|
| Femoral Fractures | 1 | 1977 | 32 | 0.000 |
Why?
|
| Ligation | 1 | 1976 | 51 | 0.000 |
Why?
|
| Renal Veins | 1 | 1976 | 28 | 0.000 |
Why?
|
| Collateral Circulation | 1 | 1976 | 35 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1976 | 155 | 0.000 |
Why?
|
| Blood Specimen Collection | 1 | 1976 | 27 | 0.000 |
Why?
|
| Accidents, Traffic | 1 | 1977 | 94 | 0.000 |
Why?
|
| Elastic Tissue | 1 | 1975 | 18 | 0.000 |
Why?
|
| Hepatic Artery | 1 | 1975 | 83 | 0.000 |
Why?
|
| Neoplasms | 1 | 1969 | 2898 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1978 | 2232 | 0.000 |
Why?
|
| Models, Biological | 1 | 1976 | 1749 | 0.000 |
Why?
|
| Infant | 1 | 1975 | 3045 | 0.000 |
Why?
|